Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-039087
Filing Date
2023-08-07
Accepted
2023-08-07 16:18:12
Documents
5
Effectiveness Date
2023-08-07

Document Format Files

Seq Description Document Type Size
1 S-8 crsp_2023_s-8_august_202.htm S-8 170520
2 EX-5.1 crsp-ex5_1.htm EX-5.1 76195
3 EX-23.1 crsp-ex23_1.htm EX-23.1 4800
4 EX-FILING FEES crsp-exfiling_fees.htm EX-FILING FEES 51038
5 GRAPHIC img33470342_0.jpg GRAPHIC 20639
  Complete submission text file 0000950170-23-039087.txt   332100
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273764 | Film No.: 231147868
SIC: 2836 Biological Products, (No Diagnostic Substances)